RxDoctor Payments Data

Rebecca McGaha, DPM

Foot & Ankle Surgery · Shreveport, LANPI 1962808097

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.8% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $443 and has fallen 78.0% since, to $97 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in LA, where the typical reported total is $2,260.

$1,337in general payments, 2019–2025

Across 62 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$308
  • Organogenesis Inc.$265
  • Smith+Nephew$150
  • Melinta Therapeutics, LLC$148
  • Averitas Pharma Inc.$109
  • GRT US Holding, Inc.$98
  • plus $258 from 10 others

What the payments were for

  • Food & beverage$1,24193%
  • Gifts$967%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,337 in reported general payments places this provider in the 45th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$105,361
Medicare patients
540
Services billed
2,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine38$3,891
Ketoconazole123$3,652
Ciclopirox93$2,974
Mupirocin225$1,765
Gabapentin58$439
Diclofenac Sodium17$382
Doxycycline Hyclate53$326
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$270
Terbinafine Hcl15$237
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$221
Cephalexin17$104
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$89
Pregabalin12$59
Amoxicillin14$47
Meloxicam13$14

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →